Comparative Outcomes of Lower Extremity Fractures in Patients With Type 1 and Type 2 Diabetes: A Retrospective
Thomas E Olson1, Christopher Hamad1, Joshua Wiener2
1Department of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
Background:
Diabetes mellitus (DM) is a major risk factor for adverse outcomes following orthopedic trauma. Although both type 1 (T1DM) and type 2 (T2DM) diabetes mellitus increase complication risk after lower extremity fracture fixation, their relative impacts remain poorly characterized.
Materials And Methods:
We performed a retrospective cohort analysis to compare postoperative outcomes in patients with T1DM and T2DM who underwent surgical fixation of lower extremity fractures. Propensity score matching was performed within anatomical fracture subgroups based on age, sex, race, body mass index, hemoglobin A1c, and nicotine dependence. Outcomes were compared using appropriate statistical tests and survival analysis.
Results:
A total of 10,464 patient-fracture encounters across 4 anatomic subgroups met inclusion criteria. After propensity score matching within each subgroup, 1,776 matched pairs (3,552 encounters) were analyzed. T1DM patients experienced higher rates of adverse outcomes compared to T2DM patients, with the greatest differences observed for infection (tibia: 7.3% vs 3.1%, P = .009; foot/ankle: 9.8% vs 1.8%, P < .001), amputation (femur: 2.9% vs 0.0%, P = .001; tibia: 2.6% vs 0.0%, P = .001), and mortality (hip: 21.8% vs 15.1%, P = .003; femur: 12.3% vs 4.4%, P < .001; tibia: 9.9% vs 2.5%, P < .001; foot/ankle: 7.5% vs 2.0%, P < .001). These risks appeared to increase distally, with the highest complication rates seen in the tibial and foot/ankle subgroups.
Conclusions:
T1DM confers a distinctly higher risk of infection, limb loss, and mortality following operative fixation of lower extremity fractures compared to T2DM, despite similar baseline characteristics after matching. These findings highlight the need for diabetes-subtype-specific perioperative management strategies to optimize outcomes in this high-risk population.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Diabetic Foot Ulcer
